Sonoma Pharmaceuticals, Inc. (SNOA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Oct 07, 16:00
1.21
0.00 (0.00%)
After-Hours: 17:45
Sonoma Pharmaceuticals Price to Book Value : 0.8782 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 0.8927 |
| October 05, 2026 | 0.8855 |
| October 02, 2026 | 0.90 |
| October 01, 2026 | 0.9072 |
| September 30, 2026 | 0.929 |
| September 29, 2026 | 0.9036 |
| September 28, 2026 | 0.9145 |
| September 25, 2026 | 0.9217 |
| September 24, 2026 | 0.9036 |
| September 23, 2026 | 0.9072 |
| September 22, 2026 | 0.9399 |
| September 21, 2026 | 0.9072 |
| September 18, 2026 | 0.929 |
| September 17, 2026 | 0.9145 |
| September 16, 2026 | 0.8927 |
| September 15, 2026 | 0.929 |
| September 14, 2026 | 0.9363 |
| September 11, 2026 | 0.9471 |
| September 10, 2026 | 0.9508 |
| September 09, 2026 | 0.9435 |
| September 08, 2026 | 0.9653 |
| September 04, 2026 | 0.9617 |
| September 03, 2026 | 0.958 |
| September 02, 2026 | 0.9363 |
| September 01, 2026 | 0.9363 |
| Date | Value |
|---|---|
| August 31, 2026 | 0.9363 |
| August 28, 2026 | 0.9508 |
| August 27, 2026 | 0.9653 |
| August 26, 2026 | 1.002 |
| August 25, 2026 | 0.9798 |
| August 24, 2026 | 0.9725 |
| August 21, 2026 | 0.9725 |
| August 20, 2026 | 0.9725 |
| August 19, 2026 | 0.9871 |
| August 18, 2026 | 0.9435 |
| August 17, 2026 | 0.958 |
| August 14, 2026 | 0.9435 |
| August 13, 2026 | 0.9725 |
| August 12, 2026 | 0.9943 |
| August 11, 2026 | 0.9943 |
| August 10, 2026 | 0.9363 |
| August 07, 2026 | 1.045 |
| August 06, 2026 | 0.9072 |
| August 05, 2026 | 0.8201 |
| August 04, 2026 | 0.8709 |
| August 03, 2026 | 0.8129 |
| July 31, 2026 | 0.7984 |
| July 30, 2026 | 0.8201 |
| July 29, 2026 | 0.7984 |
| July 28, 2026 | 0.8274 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.762 |
| Corcept Therapeutics, Inc. | 18.29 |
| Veru, Inc. | 1.484 |
| Johnson & Johnson | 7.323 |
| Eli Lilly & Co. | 33.03 |
Price to Book Value Related Metrics
| PS Ratio | 0.1238 |
| Price | 1.21 |
| Earnings Yield | -100.6% |
| Market Cap | 5.791M |